Early urate-lowering therapy and cardiometabolic risk in adults without documented major cardiometabolic disease: a real-world cohort study
Background Whether urate-lowering therapy (ULT) affects cardiometabolic outcomes in individuals without established metabolic disease remains uncertain. Materials and methods This retrospective cohort study used TriNetX data (2015–2023) to include adults with newly diagnosed hyperuricemia (UA >7 mg/dL) and no baseline...